Skip to content
Catalyst

PapersPMID:42646594

Sertraline as an Antidepressant and Inflammatory Cytokines in Depressive Disorders: A Systematic Review and Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials.

Medical sciences (Basel, Switzerland)2026The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, moderate evidenceno difference foundTumour necrosis factor alpha concentration
  2. Finding, moderate evidenceno difference foundInterleukin-6 concentration
Study, every finding
meta-analysis
Population, every finding
adults treated with sertraline for depressive disorders, pooled across trials with mixed comorbidities including coronary heart disease and chronic kidney disease

No finding here moved its endpoint.

Study record

Design
meta-analysis
Species
human
Population
adults with depressive disorders (including comorbid coronary heart disease, chronic kidney disease, and PTSD) enrolled in 10 pooled randomized placebo-controlled trials of sertraline assessing inflammatory cytokines
Participants
not reported
Comparator
placebo
Duration
not reported
Endpoints measured
3